_id
690f369dccc777a4e85d177e
Ticker
BLTE
Name
Belite Bio Inc ADR
Exchange
NASDAQ
Address
12750 High Bluff Drive, San Diego, CA, United States, 92130
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.belitebio.com
Description
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an anti-retinol-binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.
Last Close
152.44
Volume
34353
Current Price
156.36
Change
1.25
Last Updated
2026-01-20T16:44:41.061Z
Image
data:image/webp;base64,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
Ipo Date
2022-04-29T00:00:00.000Z
Market Cap
5818894848
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.99
Sentiment Sources
2
Rating
4.6
Target Price
185.2857
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
23018000
Operating Income
-23018000
Interest Expense
-
Pretax Income
-21690000
Net Income
-21690000
Eps
-0.6528564108392585
Dividends Per Share
-
Shares Outstanding
37514630
Income Tax Expense
-
EBITDA
-21690000
Operating Margin
-
Total Other Income Expense Net
1328000
Cash
157034000
Short Term Investments
118580000
Receivables
-
Inventories
-
Total Current Assets
277213000
Property Plant Equipment
826000
Total Assets
282393000
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
8311000
Equity
274082000
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
USD
PE
-
PB
18.953395536810152
ROE
-7.913690063557621
ROA
-7.680785288587182
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
34
Deep Value Investing Score
3
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
23018000
Quarters > 0 > income Statement > operating Income
-23018000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-21690000
Quarters > 0 > income Statement > net Income
-21690000
Quarters > 0 > income Statement > eps
-0.6528564108392585
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
33223232
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-21690000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1328000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
157034000
Quarters > 0 > balance Sheet > short Term Investments
118580000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
277213000
Quarters > 0 > balance Sheet > property Plant Equipment
826000
Quarters > 0 > balance Sheet > total Assets
282393000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
8311000
Quarters > 0 > balance Sheet > equity
274082000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-21690000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6528564108392585
Quarters > 0 > ratios > PB
18.953395536810152
Quarters > 0 > ratios > ROE
-7.913690063557621
Quarters > 0 > ratios > ROA
-7.680785288587182
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
17596000
Quarters > 1 > income Statement > operating Income
-17596000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-16320000
Quarters > 1 > income Statement > net Income
-16320000
Quarters > 1 > income Statement > eps
-0.5008432856755782
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
32585043
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-16278000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1276000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
150970000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
156407000
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6522000
Quarters > 1 > balance Sheet > equity
149885000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-9494
Quarters > 1 > cash Flow > depreciation
42000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5008432856755782
Quarters > 1 > ratios > PB
33.99270990079061
Quarters > 1 > ratios > ROE
-10.888347733262167
Quarters > 1 > ratios > ROA
-10.434315599685435
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
15517000
Quarters > 2 > income Statement > operating Income
-15517000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-14277000
Quarters > 2 > income Statement > net Income
-14277000
Quarters > 2 > income Statement > eps
-0.44498815609026304
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
32084000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-15475000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1240000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
159287000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
164201000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6131000
Quarters > 2 > balance Sheet > equity
158070000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-14277
Quarters > 2 > cash Flow > depreciation
42000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.44498815609026304
Quarters > 2 > ratios > PB
31.73691554374644
Quarters > 2 > ratios > ROE
-9.032074397418866
Quarters > 2 > ratios > ROA
-8.694831334766537
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
11457000
Quarters > 3 > income Statement > operating Income
-11457000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-10100000
Quarters > 3 > income Statement > net Income
-10100000
Quarters > 3 > income Statement > eps
-0.32111404317553177
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
31453000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-7579000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
1357000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
31677000
Quarters > 3 > balance Sheet > short Term Investments
113472000
Quarters > 3 > balance Sheet > receivables
594000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
147073000
Quarters > 3 > balance Sheet > property Plant Equipment
965000
Quarters > 3 > balance Sheet > total Assets
152132000
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
276000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6311000
Quarters > 3 > balance Sheet > equity
145821000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-10100
Quarters > 3 > cash Flow > depreciation
118000
Quarters > 3 > cash Flow > change In Working Capital
2423000
Quarters > 3 > cash Flow > cash From Operations
-4601000
Quarters > 3 > cash Flow > capital Expenditures
6000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
39775000
Quarters > 3 > cash Flow > net Change In Cash
8883000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.32111404317553177
Quarters > 3 > ratios > PB
33.726219680292964
Quarters > 3 > ratios > ROE
-6.926300052804465
Quarters > 3 > ratios > ROA
-6.638971419556701
Quarters > 3 > ratios > FCF
-4607000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
449000
Annuals > 0 > income Statement > gross Profit
-449000
Annuals > 0 > income Statement > operating Expenses
39996000
Annuals > 0 > income Statement > operating Income
-39996000
Annuals > 0 > income Statement > interest Expense
20000
Annuals > 0 > income Statement > pretax Income
-36138000
Annuals > 0 > income Statement > net Income
-36144000
Annuals > 0 > income Statement > eps
-1.1835599127104917
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
30538378
Annuals > 0 > income Statement > income Tax Expense
6000
Annuals > 0 > income Statement > EBITDA
-35669000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
3858000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
31677000
Annuals > 0 > balance Sheet > short Term Investments
113472000
Annuals > 0 > balance Sheet > receivables
594000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
147073000
Annuals > 0 > balance Sheet > property Plant Equipment
965000
Annuals > 0 > balance Sheet > total Assets
152132000
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
276000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6311000
Annuals > 0 > balance Sheet > equity
145821000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-36144000
Annuals > 0 > cash Flow > depreciation
449000
Annuals > 0 > cash Flow > change In Working Capital
1133000
Annuals > 0 > cash Flow > cash From Operations
-29234000
Annuals > 0 > cash Flow > capital Expenditures
151000
Annuals > 0 > cash Flow > cash From Investing
-110572000
Annuals > 0 > cash Flow > cash From Financing
83595000
Annuals > 0 > cash Flow > net Change In Cash
-56480000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.1835599127104917
Annuals > 0 > ratios > PB
32.74549470981546
Annuals > 0 > ratios > ROE
-24.786553377085603
Annuals > 0 > ratios > ROA
-23.75831514737202
Annuals > 0 > ratios > FCF
-29385000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
399000
Annuals > 1 > income Statement > gross Profit
-399000
Annuals > 1 > income Statement > operating Expenses
31668000
Annuals > 1 > income Statement > operating Income
-31668000
Annuals > 1 > income Statement > interest Expense
25000
Annuals > 1 > income Statement > pretax Income
-31623000
Annuals > 1 > income Statement > net Income
-31632000
Annuals > 1 > income Statement > eps
-1.1894558529015529
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
26593673
Annuals > 1 > income Statement > income Tax Expense
9000
Annuals > 1 > income Statement > EBITDA
-31199000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
45000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
88157000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
867000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
89940000
Annuals > 1 > balance Sheet > property Plant Equipment
1301000
Annuals > 1 > balance Sheet > total Assets
94642000
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
616000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4211000
Annuals > 1 > balance Sheet > equity
90431000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-31632000
Annuals > 1 > cash Flow > depreciation
399000
Annuals > 1 > cash Flow > change In Working Capital
-2427000
Annuals > 1 > cash Flow > cash From Operations
-29837000
Annuals > 1 > cash Flow > capital Expenditures
63000
Annuals > 1 > cash Flow > cash From Investing
-63000
Annuals > 1 > cash Flow > cash From Financing
75959000
Annuals > 1 > cash Flow > net Change In Cash
46068000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.1894558529015529
Annuals > 1 > ratios > PB
45.98187248045471
Annuals > 1 > ratios > ROE
-34.979155378133605
Annuals > 1 > ratios > ROA
-33.42279326303333
Annuals > 1 > ratios > FCF
-29900000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
26
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
198000
Annuals > 2 > income Statement > gross Profit
-198000
Annuals > 2 > income Statement > operating Expenses
12821000
Annuals > 2 > income Statement > operating Income
-12821000
Annuals > 2 > income Statement > interest Expense
16000
Annuals > 2 > income Statement > pretax Income
-12648000
Annuals > 2 > income Statement > net Income
-12648000
Annuals > 2 > income Statement > eps
-0.6331409014829154
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19976596
Annuals > 2 > income Statement > income Tax Expense
-173000
Annuals > 2 > income Statement > EBITDA
-12434000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
173000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
42089000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
19000
Annuals > 2 > balance Sheet > inventories
-19000
Annuals > 2 > balance Sheet > total Current Assets
42807000
Annuals > 2 > balance Sheet > property Plant Equipment
1378000
Annuals > 2 > balance Sheet > total Assets
44273000
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
396000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2772000
Annuals > 2 > balance Sheet > equity
41501000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-12648000
Annuals > 2 > cash Flow > depreciation
198000
Annuals > 2 > cash Flow > change In Working Capital
-491000
Annuals > 2 > cash Flow > cash From Operations
-11458000
Annuals > 2 > cash Flow > capital Expenditures
394000
Annuals > 2 > cash Flow > cash From Investing
-394000
Annuals > 2 > cash Flow > cash From Financing
36963000
Annuals > 2 > cash Flow > net Change In Cash
24745000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.6331409014829154
Annuals > 2 > ratios > PB
75.26422376713815
Annuals > 2 > ratios > ROE
-30.476374063275586
Annuals > 2 > ratios > ROA
-28.568201838592373
Annuals > 2 > ratios > FCF
-11852000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
30000
Annuals > 3 > income Statement > gross Profit
-30000
Annuals > 3 > income Statement > operating Expenses
9797000
Annuals > 3 > income Statement > operating Income
-9797000
Annuals > 3 > income Statement > interest Expense
5000
Annuals > 3 > income Statement > pretax Income
-9666000
Annuals > 3 > income Statement > net Income
-9666000
Annuals > 3 > income Statement > eps
-0.4011567890972341
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
24095317
Annuals > 3 > income Statement > income Tax Expense
126000
Annuals > 3 > income Statement > EBITDA
-9636000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
131000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
17344000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
23000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
17431000
Annuals > 3 > balance Sheet > property Plant Equipment
94000
Annuals > 3 > balance Sheet > total Assets
18348000
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
33441000
Annuals > 3 > balance Sheet > equity
-15093000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-9666000
Annuals > 3 > cash Flow > depreciation
30000
Annuals > 3 > cash Flow > change In Working Capital
640000
Annuals > 3 > cash Flow > cash From Operations
-7474000
Annuals > 3 > cash Flow > capital Expenditures
74000
Annuals > 3 > cash Flow > cash From Investing
-56000
Annuals > 3 > cash Flow > cash From Financing
-583000
Annuals > 3 > cash Flow > net Change In Cash
-8274000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.4011567890972341
Annuals > 3 > ratios > PB
-249.62192845160013
Annuals > 3 > ratios > ROE
64.04293381037567
Annuals > 3 > ratios > ROA
-52.6814911706998
Annuals > 3 > ratios > FCF
-7548000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.6528564108392585
Valuation > metrics > PB
18.953395536810152
Valuation > final Score
20
Valuation > verdict
531.8% Overvalued
Profitability > metrics > ROE
-7.913690063557621
Profitability > metrics > ROA
-7.824308383805954
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.030323042009325677
Risk > final Score
80
Risk > verdict
Low
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-1616
Prev Risks > 1
8
Prev Risks > 2
42
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2026-01-20T21:30:18.916Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-27
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.4825
Earnings History > 0 > eps Difference
0.4825
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-18
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.65
Earnings History > 1 > eps Estimate
-0.4975
Earnings History > 1 > eps Difference
-0.1525
Earnings History > 1 > surprise Percent
-30.6533
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-11
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.31
Earnings History > 2 > eps Estimate
-0.39
Earnings History > 2 > eps Difference
0.08
Earnings History > 2 > surprise Percent
20.5128
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-14
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.27
Earnings History > 3 > eps Estimate
-0.37
Earnings History > 3 > eps Difference
0.1
Earnings History > 3 > surprise Percent
27.027
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-17
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.32
Earnings History > 4 > eps Estimate
-0.32
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
0
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.28
Earnings History > 5 > eps Estimate
-0.29
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
3.4483
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-09
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.31
Earnings History > 6 > eps Estimate
-0.26
Earnings History > 6 > eps Difference
-0.05
Earnings History > 6 > surprise Percent
-19.2308
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-13
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.27
Earnings History > 7 > eps Estimate
-0.28
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
3.5714
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-11
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.25
Earnings History > 8 > eps Estimate
-0.3
Earnings History > 8 > eps Difference
0.05
Earnings History > 8 > surprise Percent
16.6667
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-13
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.4
Earnings History > 9 > eps Estimate
-0.32
Earnings History > 9 > eps Difference
-0.08
Earnings History > 9 > surprise Percent
-25
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.26
Earnings History > 10 > eps Estimate
-0.3
Earnings History > 10 > eps Difference
0.04
Earnings History > 10 > surprise Percent
13.3333
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-10
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.33
Earnings History > 11 > eps Estimate
-0.2
Earnings History > 11 > eps Difference
-0.13
Earnings History > 11 > surprise Percent
-65
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-31
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.37
Earnings History > 12 > eps Estimate
-0.17
Earnings History > 12 > eps Difference
-0.2
Earnings History > 12 > surprise Percent
-117.6471
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-30
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.11
Earnings History > 13 > eps Estimate
-0.11
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-10
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.08
Earnings History > 14 > eps Estimate
-0.23
Earnings History > 14 > eps Difference
0.15
Earnings History > 14 > surprise Percent
65.2174
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-29
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.4
Earnings History > 15 > eps Estimate
-0.28
Earnings History > 15 > eps Difference
-0.12
Earnings History > 15 > surprise Percent
-42.8571
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-01-21
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.2
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.2
Earnings History > 16 > surprise Percent
-
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an anti-retinol-binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABelite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Consensus Recommendation of “Moderate Buy” by Brokerages Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$185.2857
Analyst Picks
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.35% of the total shares of Belite Bio Inc ADR
1.
State Street Corp(0.0621%)
since
2025/06/30
2.
Geode Capital Management, LLC(0.0395%)
since
2025/06/30
3.
SPDR® Portfolio Emerging Markets ETF(0.0336%)
since
2025/08/29
4.
Marshall Wace Asset Management Ltd(0.0291%)
since
2025/06/30
5.
Citadel Advisors Llc(0.0229%)
since
2025/06/30
6.
SPDR® S&P Emerging Markets Small Cap ETF(0.0225%)
since
2025/08/29
7.
JPMorgan Chase & Co(0.0208%)
since
2025/06/30
8.
Fidelity Nasdaq Composite Index(0.0207%)
since
2025/07/31
9.
Fidelity Nasdaq Composite ETF(0.0188%)
since
2025/08/29
10.
Renaissance Technologies Corp(0.0132%)
since
2025/06/30
11.
BNP Paribas Arbitrage, SA(0.0101%)
since
2025/06/30
12.
Cubist Systematic Strategies, LLC(0.0088%)
since
2025/06/30
13.
UBS Group AG(0.0072%)
since
2025/06/30
14.
Virtus LifeSci Biotech Clinical Trls ETF(0.0061%)
since
2025/08/29
15.
ActivePassive International Equity ETF(0.0055%)
since
2025/08/29
16.
GAMMA Investing LLC(0.0049%)
since
2025/06/30
17.
Virtus Investment Advisors (VIA)(0.0046%)
since
2025/06/30
18.
SPDR® S&P China ETF(0.0043%)
since
2025/08/29
19.
Point72 Asset Management, L.P.(0.004%)
since
2025/06/30
20.
Bank of America Corp(0.0028%)
since
2025/06/30
21.
CIBC US Broad Market Index(0.0024%)
since
2025/05/31
22.
JHVIT Total Stock Market Index I(0.0017%)
since
2025/07/31
23.
Morgan Stanley - Brokerage Accounts(0.0016%)
since
2025/06/30
24.
Caitong International Asset Management Co., Limited.(0.0004%)
since
2025/06/30
25.
SBI Securities Co Ltd(0.0002%)
since
2025/06/30
26.
Advisor Group Holdings, Inc.(0%)
since
2025/06/30
27.
Goldman Sachs Group Inc(0%)
since
2025/03/31
28.
Tower Research Capital LLC(0%)
since
2025/06/30
29.
Ameriprise Financial Inc(0%)
since
2025/06/30
30.
QRG QP: Emerging Markets ADR Beta(0%)
since
2025/06/30
31.
QRG QP: Factor EM ADR VMQ(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.4825
Date
2025-09-30
EPS Actual
-0.65
EPS Estimate
-0.4975
EPS Difference
-0.1525
Surprise Percent
-30.6533%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.